Elite in Membranous Nephropathy

Hong B. Cheng

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Elite in Membranous Nephropathy
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Hong Cheng practices in Beijing, China. Ms. Cheng is rated as an Elite expert by MediFind in the treatment of Membranous Nephropathy. Her top areas of expertise are Membranous Nephropathy, Glomerulonephritis, Congenital Hyperinsulinism, Heart Bypass Surgery, and Tissue Biopsy.

Her clinical research consists of co-authoring 507 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 15 articles in the study of Membranous Nephropathy.

Gender
Female

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Other Locations
300# Guangzhou Road, Nanjing, 210029, China
No. 519 East Beijing Road, Nanchang, 330029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Study of Efficacy and Safety of Automated Peritoneal Dialysis in Urgent Start Dialysis as Compared With Intermittent Hemodialysis in ESRD Patients,a Multi-center, Non-blind and Controlled Clinical Trial
The Study of Efficacy and Safety of Automated Peritoneal Dialysis in Urgent Start Dialysis as Compared With Intermittent Hemodialysis in ESRD Patients,a Multi-center, Non-blind and Controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: June 08, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

507 Total Publications

METTL14 Inhibits the Pyroptosis of Neurons in Parkinson's Disease via Upregulating NFE2.
METTL14 Inhibits the Pyroptosis of Neurons in Parkinson's Disease via Upregulating NFE2.
Journal: Critical reviews in eukaryotic gene expression
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cheng's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 80 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile